Skip to main content
. 2021 Jan 8;22(2):587. doi: 10.3390/ijms22020587

Figure 2.

Figure 2

EGFR-based therapies in glioblastoma. (BBB—blood brain barrier, mABs—monoclonal antibodies, CAR-T—Chimeric anti-gen receptor T cell therapy)